Home > Insider Trading > Filing (0001179110-14-002599)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1586105	Egalet Corp	EGLT	Pharmaceutical Preparations (2834)	463575334

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1346450	P L Vii Fund Venture Atlas	25 First Street Suite 303 Cambridge MA 02141		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-11	833,098	$0.00	833,098	No	4	C	Direct
Common Stock	Acquisiton	2014-02-11	863,754	$0.00	1,696,852	No	4	C	Direct
Common Stock	Acquisiton	2014-02-11	30,000	$0.00	1,726,852	No	4	X	Direct
Common Stock	Acquisiton	2014-02-11	298,083	$6.00	2,024,935	No	4	C	Direct
Common Stock	Acquisiton	2014-02-11	85,620	$6.00	2,110,555	No	4	C	Direct
Common Stock	Acquisiton	2014-02-11	41,667	$12.00	2,152,222	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2014-02-11	833,098	$0.00	833,098	$0.00
Common Stock	Series B Preferred Stock	Disposition	2014-02-11	863,754	$0.00	863,754	$0.00
Common Stock	Warrants	Disposition	2014-02-11	30,000	$0.00	30,000	$0.00
Common Stock	Subordinated Convertible Debt	Disposition	2014-02-11	0	$0.00	298,083	$6.00
Common Stock	Senior Convertible Debt	Disposition	2014-02-11	0	$0.00	85,620	$6.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	C	Direct
No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	308,727	Indirect	By Egalet A/S

Footnotes

The reporting person is Egalet A/S, a corporation. Atlas Venture Fund VII, L.P. ("Atlas Venture Fund") is a 23.9% equityholder of Egalet A/S.
The Series A-1 Preferred Stock automatically converted into Egalet Corporation common stock on a 1-for-1 basis immediately prior to the consummation of Egalet Corporation's initial public offering.
The Series B Preferred Stock automatically converted into Egalet Corporation common stock on a 1-for-1 basis immediately prior to the consummation of Egalet Corporation's initial public offering.
The warrants were automatically exercised into Egalet Corporation common stock immediately prior to the consummation of the Egalet Corporation's initial public offering on a 1-for-1 basis, pursuant to Atlas Venture Fund's purchase of a specified minimum amount of common stock in such offering.
The subordinated convertible debt automatically converted into Egalet Corporation common stock immediately prior to the consummation of Egalet Corporation's initial public offering, based on a conversion price equal to 50% of the per share price in such offering, which was $12 per share.
The senior convertible debt automatically converted into Egalet Corporation common stock immediately prior to the consummation of Egalet Corporation's initial public offering, based on a conversion price equal to 50% of the per share price in such offering, which was $12 per share.